Deferasirox

FDA Approved: * January 26, 2016
Pharm Company: * ACTAVIS ELIZABETH
Category: Iron Chelator

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Deferasirox Overview

Deferasirox, sold under the brand name Exjade among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[2][3] It is the first oral medication approved in the United States for this purpose.[4] It was approved by the U.S.Food and Drug Administration (FDA) in November 2005.[2]&...

Read more Deferasirox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deferasirox

Recent Deferasirox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Deferasirox
  • Granule: 180mg, 360mg, 90mg
  • Tablet: 180mb, 180mg, 360mg, 90mg
  • Tablet, Film Coated: 90 Mg, 180 Mg, 360 Mg.
  • Tablet, For Suspension: 125mg, 250mg, 500mg
  • Tablet, Orally Disintegrating: 500mg
  • Unknown: Unknown
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Deferasirox: (87 results)

Showing the first 20, Sorted by National Drug Code
  • 0078-0654 Jadenu 90 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0655 Jadenu 180 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0656 Jadenu 360 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0093-3515 Deferasirox 360 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-3516 Deferasirox 180 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
  • 0093-3517 Deferasirox 90 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0591-3853 Deferasirox 180 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 16714-993 Deferasirox 90 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-994 Deferasirox 180 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-995 Deferasirox 360 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 31722-011 Deferasirox 90 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-012 Deferasirox 180 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-013 Deferasirox 360 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 43598-851 Deferasirox 360 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • 43598-852 Deferasirox 180 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • 43598-853 Deferasirox 90 mg Oral Tablet by Dr. Reddy's Laboratories Inc
  • 43598-854 Deferasirox 500 mg Oral Tablet, for Suspension by Dr. Reddy's Laboratories Inc
  • 43598-855 Deferasirox 125 mg Oral Tablet, for Suspension by Dr. Reddy's Laboratories Inc
  • 43598-856 Deferasirox 250 mg Oral Tablet, for Suspension by Dr. Reddy's Laboratories Inc
  • 45963-454 Deferasirox 125 mg Oral Tablet, for Suspension by Actavis Pharma, Inc.
  • 67 more results ...

Other drugs which contain Deferasirox or a similar ingredient: (2 results)